International Symposium in Quantitative Pharmacology in Drug Development and Regulation, Nanjing, China

Dear colleagues and friends, The International Symposium in Quantitative Pharmacology (ISQP) in Drug Development and Regulation will be held at the International Conference Hotel of Nanjing, China from Oct 29 to 31. The theme of this symposium is "Building A Successful Pharmaceutical Industry Through Globalization and Implementation of Quantitative Methodologies for Efficient Drug Development and Approval". China is becoming an increasingly attractive destination for pharmaceutical research and clinical trials. The ISQP will highlight the challenges and opportunities in this rapidly evolving country. This three - day meeting will provide an international forum for scientific exchange in recent advancements in clinical pharmacology and pharmacometrics. It will bring together leading academic, regulatory and industry scientists worldwide to discuss quantitative methodology as a critical tool in decision making during drug development and approval. Furthermore, it will offer an avenue to discuss future environment for partnering strategy in this very challenging scientific frontier. The conference will consist of three plenary morning sessions and three afternoon sessions with 2 parallel symposia, one focus on globalization and China, and one on quantitative pharmacology. The preliminary program, registration and updated information can be found on ISQP Nanjing 2007 website at www.qpharmmeeting.com http://www.qpharmmeeting.com/ . The ISQP is a great opportunity for learning, sharing, exploring and networking. Welcome to ISQP Nanjing 2007! Sponsors Co-sponsors Chinese Journal of Clinical Pharmacology and Therapeutics American College of Clinical Pharmacology Chinese Society of Quantitative Pharmacology American Association of Pharmaceutical Scientists Chinese Society of Pharmacokinetics China Pharmaceutical University Chinese State FDA Jiangsu Drug Research and Development Association This e-mail and its attachments may contain Forest Laboratories, Inc. proprietary information that is privileged, confidential or subject to copyright belonging to Forest Laboratories, Inc. This e-mail is intended solely for the use of the individual or entity to which it is addressed. If you are not the intended recipient of this e-mail, or the employee or agent responsible for delivering this e-mail to the intended recipient, you are hereby notified that any dissemination, distribution, copying or action taken in relation to the contents of and attachments to this e-mail is strictly prohibited and may be unlawful. If you have received this e-mail in error, please notify the sender immediately and permanently delete the original and any copy of this e-mail and any printout.